2-Aminonicotinamide

Catalog No.: 
ACQSHA803
CAS No.: 
13438-65-8
Molecular Formula: 
C6H7N3O
Molecular Weight: 
137.14
2-Aminonicotinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$59.00In stockIn stock
25g95%$139.00In stockIn stock
100g95%$539.00In stockInquiry
500g95%$2156.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Aminonicotinamide
IUPAC Name2-aminonicotinamide
MDL No.MFCD00128873
Molecular FormulaC6H7N3O
Molecular Weight137.14
SMILESO=C(N)C1=C(N)N=CC=C1
InChI KeyHTPCDVLWYUXWQR-UHFFFAOYSA-N
Synonym2-aminopyridine-3-carboxamide | AM20050775 | ar-Amino-3-pyridinecarboxamide | 3-(4-nitro-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine | AKOS027338692 | SCHEMBL13686500 | SCHEMBL11628825 | 2-aminonicotinamide;2-AMINOPYRIDINE-3-CARBOXAMIDE | AC-2
CAS No.13438-65-8
PubChem CID506623

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACQSHA803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCQHX372 route compound structure diagram
    ACCQHX37224517-64-4In Stock
  2. Then
  3. ACQSHA803 route product structure diagram
    ACQSHA80313438-65-8In Stock
Inquiry

2. ACQSHA803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXWBF904 route compound structure diagram
    ACXWBF90414667-47-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACQSHA803 route product structure diagram
    ACQSHA80313438-65-8In Stock
Inquiry

3. ACQSHA803 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQSHA803 route product structure diagram
    ACQSHA80313438-65-8In Stock
Inquiry

Comments (0)